glp-1 receptor meds Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Research shows GLP-1 drugs are

A recent study published in JAMA Ophthalmology found a striking association between semaglutide use and nonarteritic anterior ischemic optic neuropathy (NAION), a leading cause of sudden vision loss

Fasting and Stimulated Glucagon-Like Peptide-1 Exhibit a Compensatory Adaptive Response in Diabetes and Pre-Diabetes States: A Multi-Ethnic Comparative Study

Since no human clinical trials exist, these numbers are based on animal research and years of community experience

Schalkwijk CG, Stehouwer CD

[3] For chronic conditions such as inflammatory bowel disease or persistent gut permeability, longer-duration protocols of eight to twelve weeks have been explored in preclinical literature